bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: Alvogen Inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler Alvogen Inc.
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

BUPROPION HYDROCHLORIDE 450 mg/1

Identifiers & Regulatory

Product NDC 47781-637
Product ID 47781-637_e6291f65-f3fd-7567-c756-ce326933a2ec
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA022497
Marketing Start 2018-09-28
Marketing End 2026-03-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 47781637
Hyphenated Format 47781-637

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number NDA022497 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 450 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-637-30)
source: ndc

Packages (1)

47781-637-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-637-30)

Ingredients (1)

BUPROPION HYDROCHLORIDE (450 mg/1)

Linked Drug Pages (1)

bupropion hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e6291f65-f3fd-7567-c756-ce326933a2ec", "openfda": {"upc": ["0347781637309"], "unii": ["ZG7E5POY8O"], "rxcui": ["1232585"], "spl_set_id": ["a032e7c8-33f2-5fdb-62d7-8517072d1d10"], "manufacturer_name": ["Alvogen Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-637-30)", "package_ndc": "47781-637-30", "marketing_end_date": "20260301", "marketing_start_date": "20180928"}], "brand_name": "bupropion hydrochloride", "product_id": "47781-637_e6291f65-f3fd-7567-c756-ce326933a2ec", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "47781-637", "generic_name": "bupropion hydrochloride", "labeler_name": "Alvogen Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "450 mg/1"}], "application_number": "NDA022497", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20260301", "marketing_start_date": "20180928"}